Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 2,381	$ 1,245
General and administrative	3,764	1,118
Total operating expenses	6,145	2,363
Loss from operations	(6,145)	(2,363)
Net loss	(6,145)	(2,363)
Net loss attributable to common stockholders (Note 10)	$ (6,145)	$ (3,069)
Net loss per share attributable to common stockholders – basic and diluted	$ (0.33)	$ (0.82)
Weighted-average number of shares used in computing net loss per common share, basic and diluted	18,800,546	3,764,488